Coronavirus Vaccines
Producing a low-cost Covid-19 jab for the developing world
US project to develop 'people's vaccine' needed support from wide range of donors
Sign up now: Get insights on Asia's fast-moving developments
Dr Maria Elena Bottazzi and Dr Peter Hotez in their lab at Texas Children's Hospital Centre for Vaccine Development. The Covid-19 vaccine developed at the centre in Houston is expected to be ready for public use in India around next month and made available to others later through the Covid-19 Vaccine Global Access Facility.
PHOTO: BAYLOR COLLEGE OF MEDICINE
Debarshi Dasgupta India Correspondent In New Delhi, Debarshi Dasgupta
It is a low-cost Covid-19 vaccine that today holds out hope for low-and middle-income countries that have been elbowed out by richer nations in a scramble for vaccines.
But attaining this pedestal has not been easy for the team of researchers behind this vaccine in the United States, who have had to jump through several hoops to get this far.
